The p.Gly2019Ser is a common LRRK2 pathogenic variant among Egyptians with familial and sporadic Parkinson’s disease

Martina B. William(American University in Cairo), Mie Rizig(National Hospital for Neurology and Neurosurgery), Gaafar Ragab(Cairo University), Eman M. Khedr(Assiut University Hospitals), Jaidaa Mekky(Alexandria University), Gharib Fawi(Sohag University), Mohamed Essam(Ain Shams University), Sara Elfarrash(Mansoura University), Sherifa A. Hamed(Assiut University), Ali Shalash(Ain Shams University), Mohamed Elgamal(Mansoura University), Mohamed Hussein(Cairo University), Samir Nabhan(Hôpital Saint-Louis), Alina Jama(National Hospital for Neurology and Neurosurgery), Nourhan Shebl(American University in Cairo), Doaa M. Mahmoud(Assiut University), Shimaa Elgamal(Kafrelsheikh University), Eman Hamid(Ain Shams University), Asmaa Gabr(American University in Cairo), Mohamed Salama(American University in Cairo), Mohamed H. Yousef(American University in Cairo), Henry Houlden(University College London), Salma Ragab(Kafrelsheikh University), Mohamed Tharwat Hegazy(Cairo University), Nesreen Abdelwahhab(Mansoura University), Asmaa Helmy(Al-Azhar University), Tamer Belal(Mansoura University), N. El-Sayed, Yasmin Elsaid(Mansoura University), Lobna Abdel Aziz Aly(Alexandria University), Mohamed Koraym(Assiut University), Shaimaa I El-Jaafary(Cairo University)
npj Parkinson s Disease
November 6, 2024
Cited by 8


Related Papers